Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–9 of 9 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
NCT07222215
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06586957
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
- Locations
-
- University of Arkansas Medical School Little Rock, Arkansas, United States
- University of California - Los Angeles Los Angeles, California, United States
- UCSF San Francisco, California, United States
- SCRI at HealthOne Denver, Colorado, United States
NCT05735080
- Conditions
- Adnexal Diseases, Advanced Cancer, Breast Cancer, +29 more
- Locations
-
- Florida Cancer Specialists Orlando, Florida, United States
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
NCT02668666
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +8 more
- Locations
-
- University of Illinois Cancer Center Chicago, Illinois, United States
- Michigan State University Lansing, Michigan, United States
- University of Minnesota Minneapolis, Minnesota, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT03854903
- Conditions
- Breast Diseases, Breast Neoplasms, Hormone Receptor Positive Breast Cancer, +10 more
- Locations
-
- Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
NCT06463626
- Conditions
- Hormone-receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
NCT02871791
- Conditions
- Hormone Receptor (HR)-Positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
NCT01288261
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +9 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
Active, Not Recruiting
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
NCT02623972
- Conditions
- Breast Diseases, Breast Neoplasms, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, +6 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States